Metabolic Dysfunction-Associated Steatotic Liver Disease and Sudden Cardiac Death: Epidemiology, Mechanisms, Risk Stratification, and Prevention.
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic metabolic liver disease worldwide. Cardiovascular adverse events have long been the leading cause of death in the MASLD population, far exceeding liver-related mortality. Sudden cardiac death (SCD) represents the...